For the Inventor, By the Inventor

Enter assignee name

Richmond, VA, United States of America

Celtrix Pharmaceuticals, Inc.

USPTO Granted Patents = 45

Forward Citations = 1,218

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Desmond D Mascarenhas (15 out of 31 patents)

Yasushi Ogawa (7 out of 12 patents)

Andreas Sommer (6 out of 8 patents)

4. David K Schmidt (5 out of 5 patents)

5. Pamela S Olson (5 out of 6 patents)

6. Joseph A Carlino (5 out of 6 patents)

7. Yang Zhang (4 out of 8 patents)

8. David R Olsen (4 out of 10 patents)

9. James R Dasch (4 out of 7 patents)

10. Rosa Armstrong (4 out of 15 patents)

11. Carol Talkington-Verser (4 out of 4 patents)

12. Christopher A Maack (4 out of 4 patents)

13. Emerald Martin Spencer (4 out of 4 patents)

14. Andrea Y Thompson (3 out of 6 patents)

15. Doran R Pace, Iii (3 out of 5 patents)

Core Competencies:

Insulin-Like Growth Factor

IGF Binding Protein Variants

Ophthalmic Disorders

Chronic Stress-Related Disorders

Bone Formation

Recombinant Proteins

Transforming Growth Factor

Hematopoietic Progenitor Cells

Inflammatory Cytokines

Monoclonal Antibodies

Metabolic Disorders

Drug Response Prediction

45 patents: Sort by Forward Citations

1. 7288516 - Null IGF for the treatment of cancer (2007-10-30),

2. 6518238 - Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 (2003-02-11),

3. 6514937 - Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 (2003-02-04),

4. 6436897 - Pharmaceutical formulations for IGF/IGFBP (2002-08-20),

5. 6417330 - Insulin-like growth factor binding protein variants (2002-07-09),

6. 6124259 - Method for treating ophthalmic disorders with IGFBP (2000-09-26),

7. 6087090 - Methods for predicting drug response (2000-07-11),

8. 6040292 - Methods for treating diabetes (2000-03-21),

9. 6025368 - Method for treating the symptoms of chronic stress-related disorders (2000-02-15),

10. 6025332 - Method for treating low circulating levels of sex hormone steroids (2000-02-15),

11. 6017885 - IGF/IGFBP complex for promoting bone formation and for regulating bone (2000-01-25),

12. 6015786 - Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 (2000-01-18),

13. 5948757 - High dose IGF-1 therapy (1999-09-07),

14. 5914390 - Methods for increasing yields of recombinant proteins (1999-06-22),

15. 5914254 - Expression of fusion polypeptides transported out of the cytoplasm (1999-06-22),

Celtrix Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for a wide range of medical conditions. With a focus on research and development, Celtrix aims to discover and advance breakthrough treatments using cutting-edge technologies. The company is committed to improving patients' lives by addressing unmet medical needs and creating new therapeutic options. Through strategic collaborations and a dedicated team of experts, Celtrix is poised to make a significant impact in the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

45 Patents

#17 in Richmond, VA

#128 in Virginia

#7,763 in US

#15,403 in the World

Richmond, VA, United States of America

Celtrix Pharmaceuticals, Inc.

Forward Citations = 1,218

41 inventors:

Desmond D Mascarenhas (15 out of 31 patents)

Yasushi Ogawa (7 out of 12 patents)

Andreas Sommer (6 out of 8 patents)

4. David K Schmidt (5 out of 5 patents)

5. Pamela S Olson (5 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…